- Pitney Bowes Inc. (NYSE:PBI) and Narvar have established a joint partnership to help retail brands streamline their processes for merchandise returns.
- The new integration of physical and digital returns capabilities will enable retailers to control costs and improve customer experiences.
- “The combination of physical and digital capabilities in this joint offering from Pitney Bowes and Narvar will allow merchants to easily test and design the most pragmatic post-purchase experience for their consumers,” commented Gregg Zegras, EVP and President, Pitney Bowes Global Ecommerce.
- Price Action: PBI shares are trading higher by 3.82% at $3.39 on the last check Monday.
Aligos Therapeutics Announced Friday A Research Collaboration And Development Agreement With Xiamen Amoytop Biotech Co. Ltd. For Use Of Aligos’ Oligonucleotide Platform For Treatment Of Liver Diseases
Aligos Therapeutics, Inc. (NASDAQ:ALGS, ", Aligos", , the ", Company", )))), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and
